EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Simvastatin Blocks Blood-Brain Barrier Disruptions Induced by Elevated Cholesterol Both In Vivo and In Vitro

Xijuan Jiang, Maojuan Guo, Jinling Su, Bin Lu, Dongming Ma, Ruifeng Zhang, Lin Yang, Qiang Wang, Yiwen Ma, Yingchang Fan

International Journal of Alzheimer's Disease · 2012

DOI: 10.1155/2012/109324 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Alzheimer's Disease, 2012. Verfasst von Xijuan Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: National Natural Science Foundation of China, Doctoral Program Foundation of Institutions of Higher Education of China, Natural Science Foundation of Tianjin, China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypercholesterolemia and disruptions of the blood brain barrier (BBB) have been implicated as underlying mechanisms in the pathogenesis of Alzheimer's disease (AD). Simvastatin therapy may be of benefit in treating AD; however, its mechanism has not been yet fully understood.

Objective

To explore whether simvastatin could block disruption of BBB induced by cholesterol both in vivo and in vitro.

Methods

New Zealand rabbits were fed cholesterol-enriched diet with or without simvastatin. Total cholesterol of serum and brain was measured. BBB dysfunction was evaluated. To further test the results in vivo, rat brain microvascular endothelial cells (RBMECs) were stimulated with cholesterol in the presence/absence of simvastatin in vitro. BBB disruption was evaluated.

Results

Simvastatin blocked cholesterol-rich diet induced leakage of Evan's blue dye. Cholesterol content in the serum was affected by simvastatin, but not brain cholesterol. Simvastatin blocked high-cholesterol medium-induced decrease in TEER and increase in transendothelial FITC-labeled BSA Passage in RBMECs.

Conclusions

The present study firstly shows that simvastatin improves disturbed BBB function both in vivo and in vitro. Our data provide that simvastatin may be useful for attenuating disturbed BBB mediated by hypercholesterolemia.

Autor:innen und Institutionen

  • Department of Pathology, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.

Förderung

  • National Natural Science Foundation of China
  • Doctoral Program Foundation of Institutions of Higher Education of China
  • Natural Science Foundation of Tianjin, China
  • Health Bureau Foundation of Tianjin, China
  • Tianjin Education Foundation of Tianjin, China

Zitieren

APA

Jiang, X., Guo, M., Su, J., Lu, B., Ma, D., Zhang, R., Yang, L., Wang, Q., Ma, Y., & Fan, Y. (2012). Simvastatin Blocks Blood-Brain Barrier Disruptions Induced by Elevated Cholesterol Both In Vivo and In Vitro. International Journal of Alzheimer's Disease. https://doi.org/10.1155/2012/109324

Vancouver

Jiang X, Guo M, Su J, Lu B, Ma D, Zhang R, et al. Simvastatin Blocks Blood-Brain Barrier Disruptions Induced by Elevated Cholesterol Both In Vivo and In Vitro. International Journal of Alzheimer's Disease. 2012. doi:10.1155/2012/109324

BibTeX
@article{Jiang2012,
  author = {Jiang, Xijuan and Guo, Maojuan and Su, Jinling and Lu, Bin and Ma, Dongming and Zhang, Ruifeng and Yang, Lin and Wang, Qiang and Ma, Yiwen and Fan, Yingchang},
  title = {Simvastatin Blocks Blood-Brain Barrier Disruptions Induced by Elevated Cholesterol Both In Vivo and In Vitro},
  journal = {International Journal of Alzheimer's Disease},
  year = {2012},
  doi = {10.1155/2012/109324}
}
Kostenlos starten →